Experience with probucol in the treatment of hypercholesterolemia. 1982

J Davignon, and S Lussier-Cacan, and S Dubreuil-Quidoz, and J LeLorier

UI MeSH Term Description Entries
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D011341 Probucol A drug used to lower LDL and HDL cholesterol yet has little effect on serum-triglyceride or VLDL cholesterol. (From Martindale, The Extra Pharmacopoeia, 30th ed, p993). Biphenabid,DH-581,Lorelco,Lurselle,Panavir,Superlipid,DH 581,DH581
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D002995 Clofibric Acid An antilipemic agent that is the biologically active metabolite of CLOFIBRATE. Clofibrinic Acid,2-(4-Chlorophenoxy)-2-methylpropionic Acid,NSC-1149,p-Chlorophenoxyisobutyrate,p-Chlorophenoxyisobutyric Acid,NSC 1149,NSC1149
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J Davignon, and S Lussier-Cacan, and S Dubreuil-Quidoz, and J LeLorier
July 1981, Arquivos brasileiros de cardiologia,
J Davignon, and S Lussier-Cacan, and S Dubreuil-Quidoz, and J LeLorier
April 1984, Annals of internal medicine,
J Davignon, and S Lussier-Cacan, and S Dubreuil-Quidoz, and J LeLorier
January 1988, General pharmacology,
J Davignon, and S Lussier-Cacan, and S Dubreuil-Quidoz, and J LeLorier
November 1989, DICP : the annals of pharmacotherapy,
J Davignon, and S Lussier-Cacan, and S Dubreuil-Quidoz, and J LeLorier
September 1986, International journal of clinical pharmacology, therapy, and toxicology,
J Davignon, and S Lussier-Cacan, and S Dubreuil-Quidoz, and J LeLorier
May 1982, Canadian Medical Association journal,
J Davignon, and S Lussier-Cacan, and S Dubreuil-Quidoz, and J LeLorier
June 1986, The American journal of cardiology,
J Davignon, and S Lussier-Cacan, and S Dubreuil-Quidoz, and J LeLorier
July 1994, Digestive diseases and sciences,
J Davignon, and S Lussier-Cacan, and S Dubreuil-Quidoz, and J LeLorier
April 1980, Arquivos brasileiros de cardiologia,
J Davignon, and S Lussier-Cacan, and S Dubreuil-Quidoz, and J LeLorier
January 1991, Archivos del Instituto de Cardiologia de Mexico,
Copied contents to your clipboard!